Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human nerve growth factor

EU orphan designation number: EU/3/13/1135   
Active ingredient: Recombinant human nerve growth factor
Indication: Treatment of retinitis pigmentosa
Sponsor: Dompé S.p.A.
Via Campo di Pile, 67100 L'Aquila, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/015/13 (2013)3670 of 07/06/2013